Publications by authors named "Autumn J McRee"

22Publications

ASGE guideline on the role of endoscopy in the management of benign and malignant gastroduodenal obstruction.

Authors:
Terry L Jue Andrew C Storm Mariam Naveed Douglas S Fishman Bashar J Qumseya Autumn J McRee Mark J Truty Mouen A Khashab Deepak Agrawal Mohammed Al-Haddad Stuart K Amateau James L Buxbaum Audrey H Calderwood John DeWitt Christopher J DiMaio Larissa L Fujii-Lau Suryakanth R Gurudu Laith H Jamil Richard S Kwon Joanna K Law Jeffrey K Lee Swati Pawa Mandeep S Sawhney Nirav C Thosani Julie Yang Sachin B Wani

Gastrointest Endosc 2021 Feb 7;93(2):309-322.e4. Epub 2020 Nov 7.

Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

View Article and Find Full Text PDF
February 2021

-Mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer.

Authors:
Gary Middleton Yiqun Yang Catarina D Campbell Thierry André Chloe E Atreya Jan H M Schellens Takayuki Yoshino Johanna C Bendell Antoine Hollebecque Autumn J McRee Salvatore Siena Michael S Gordon Josep Tabernero Rona Yaeger Peter J O'Dwyer Filip De Vos Eric Van Cutsem John M Millholland Jan C Brase Fatima Rangwala Eduard Gasal Ryan B Corcoran

Clin Cancer Res 2020 06 11;26(11):2466-2476. Epub 2020 Feb 11.

Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF
June 2020

B cell-Derived IL35 Drives STAT3-Dependent CD8 T-cell Exclusion in Pancreatic Cancer.

Authors:
Bhalchandra Mirlekar Daniel Michaud Samuel J Lee Nancy P Kren Cameron Harris Kevin Greene Emily C Goldman Gaorav P Gupta Ryan C Fields William G Hawkins David G DeNardo Naim U Rashid Jen Jen Yeh Autumn J McRee Benjamin G Vincent Dario A A Vignali Yuliya Pylayeva-Gupta

Cancer Immunol Res 2020 03 5;8(3):292-308. Epub 2020 Feb 5.

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.

View Article and Find Full Text PDF
March 2020

Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET).

Authors:
Ranjit Joseph Autumn J McRee Stephanie Mathews Joshua F Zeidner

Leuk Lymphoma 2019 11 23;60(11):2793-2797. Epub 2019 May 23.

Division of Hematology/Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article and Find Full Text PDF
November 2019

Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.

Authors:
Hanna K Sanoff Dominic H Moon Dominic T Moore Jeremiah Boles Courtney Bui William Blackstock Bert H O'Neil Somasundaram Subramaniam Autumn J McRee Cheryl Carlson Michael S Lee Joel E Tepper Andrew Z Wang

Nanomedicine 2019 06 8;18:189-195. Epub 2019 Mar 8.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC; Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellent, Carolina Institute of Nanomedicine, University of North Carolina, Chapel Hill, NC. Electronic address:

View Article and Find Full Text PDF
June 2019

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance.

Authors:
Anna S Griffith Paul H Hayashi Lauren Mb Burke Autumn J McRee

J Hepatocell Carcinoma 2018 31;5:55-59. Epub 2018 May 31.

Department of Medicine.

View Article and Find Full Text PDF
May 2018

Combined BRAF, EGFR, and MEK Inhibition in Patients with -Mutant Colorectal Cancer.

Authors:
Ryan B Corcoran Thierry André Chloe E Atreya Jan H M Schellens Takayuki Yoshino Johanna C Bendell Antoine Hollebecque Autumn J McRee Salvatore Siena Gary Middleton Kei Muro Michael S Gordon Josep Tabernero Rona Yaeger Peter J O'Dwyer Yves Humblet Filip De Vos A Scott Jung Jan C Brase Savina Jaeger Severine Bettinger Bijoyesh Mookerjee Fatima Rangwala Eric Van Cutsem

Cancer Discov 2018 04 5;8(4):428-443. Epub 2018 Feb 5.

University Hospitals Leuven and KU Leuven, Leuven, Belgium.

View Article and Find Full Text PDF
April 2018

A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.

Authors:
Autumn J McRee Paul K Marcom Dominic T Moore William C Zamboni Zachary A Kornblum Zhiyuan Hu Rachel Phipps Carey K Anders Katherine Reeder-Hayes Lisa A Carey Karen E Weck Charles M Perou E Claire Dees

Clin Breast Cancer 2018 08 28;18(4):289-297. Epub 2017 Oct 28.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

View Article and Find Full Text PDF
August 2018

A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution.

Authors:
Grace R Anderson Peter S Winter Kevin H Lin Daniel P Nussbaum Merve Cakir Elizabeth M Stein Ryan S Soderquist Lorin Crawford Jim C Leeds Rachel Newcomb Priya Stepp Catherine Yip Suzanne E Wardell Jennifer P Tingley Moiez Ali Mengmeng Xu Meagan Ryan Shannon J McCall Autumn J McRee Christopher M Counter Channing J Der Kris C Wood

Cell Rep 2017 07;20(4):999-1015

Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27710, USA. Electronic address:

View Article and Find Full Text PDF
July 2017

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.

Authors:
Farshad Farshidfar Siyuan Zheng Marie-Claude Gingras Yulia Newton Juliann Shih A Gordon Robertson Toshinori Hinoue Katherine A Hoadley Ewan A Gibb Jason Roszik Kyle R Covington Chia-Chin Wu Eve Shinbrot Nicolas Stransky Apurva Hegde Ju Dong Yang Ed Reznik Sara Sadeghi Chandra Sekhar Pedamallu Akinyemi I Ojesina Julian M Hess J Todd Auman Suhn K Rhie Reanne Bowlby Mitesh J Borad Andrew X Zhu Josh M Stuart Chris Sander Rehan Akbani Andrew D Cherniack Vikram Deshpande Taofic Mounajjed Wai Chin Foo Michael S Torbenson David E Kleiner Peter W Laird David A Wheeler Autumn J McRee Oliver F Bathe Jesper B Andersen Nabeel Bardeesy Lewis R Roberts Lawrence N Kwong

Cell Rep 2017 06;19(13):2878-2880

View Article and Find Full Text PDF
June 2017

Multidisciplinary Approach to the Management of Esophageal Malignancies.

Authors:
Ranjit Joseph Shachar Laks Michael Meyers Autumn J McRee

World J Surg 2017 07;41(7):1726-1733

Department of Hematology and Oncology, The University of North Carolina, 170 Manning Drive, CB #7305, Chapel Hill, NC, 27599, USA.

View Article and Find Full Text PDF
July 2017

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.

Authors:
Farshad Farshidfar Siyuan Zheng Marie-Claude Gingras Yulia Newton Juliann Shih A Gordon Robertson Toshinori Hinoue Katherine A Hoadley Ewan A Gibb Jason Roszik Kyle R Covington Chia-Chin Wu Eve Shinbrot Nicolas Stransky Apurva Hegde Ju Dong Yang Ed Reznik Sara Sadeghi Chandra Sekhar Pedamallu Akinyemi I Ojesina Julian M Hess J Todd Auman Suhn K Rhie Reanne Bowlby Mitesh J Borad Andrew X Zhu Josh M Stuart Chris Sander Rehan Akbani Andrew D Cherniack Vikram Deshpande Taofic Mounajjed Wai Chin Foo Michael S Torbenson David E Kleiner Peter W Laird David A Wheeler Autumn J McRee Oliver F Bathe Jesper B Andersen Nabeel Bardeesy Lewis R Roberts Lawrence N Kwong

Cell Rep 2017 03;18(11):2780-2794

Departments of Genomic Medicine, Melanoma Medical Oncology, Bioinformatics and Computational Biology, Pathology, and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article and Find Full Text PDF
March 2017

A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan.

Authors:
James M Cleary Autumn J McRee Geoffrey I Shapiro Sara M Tolaney Bert H O'Neil Jeffrey D Kearns Sara Mathews Rachel Nering Gavin MacBeath Akos Czibere Sunil Sharma W Michael Korn

Invest New Drugs 2017 02 16;35(1):68-78. Epub 2016 Nov 16.

University of California - San Francisco, Box 1705, UCSF, San Francisco, CA, 94143-1705, USA.

View Article and Find Full Text PDF
February 2017

Checkpoint inhibition for colorectal cancer: progress and possibilities.

Authors:
Barry Paul Bert H O'Neil Autumn J McRee

Immunotherapy 2016 06;8(6):693-704

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

View Article and Find Full Text PDF
June 2016

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.

Authors:
Kei Muro Hyun Cheol Chung Veena Shankaran Ravit Geva Daniel Catenacci Shilpa Gupta Joseph Paul Eder Talia Golan Dung T Le Barbara Burtness Autumn J McRee Chia-Chi Lin Kumudu Pathiraja Jared Lunceford Kenneth Emancipator Jonathan Juco Minori Koshiji Yung-Jue Bang

Lancet Oncol 2016 Jun 3;17(6):717-726. Epub 2016 May 3.

Seoul National University College of Medicine, Seoul, South Korea.

View Article and Find Full Text PDF
June 2016

A phase I trial of mFOLFOX6 combined with the oral PI3K inhibitor BKM120 in patients with advanced refractory solid tumors.

Authors:
Autumn J McRee Hanna K Sanoff Cheryl Carlson Anastasia Ivanova Bert H O'Neil

Invest New Drugs 2015 Dec 21;33(6):1225-31. Epub 2015 Oct 21.

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.

View Article and Find Full Text PDF
December 2015

The Role of HIPEC in Gastrointestinal Malignancies: Controversies and Conclusions.

Authors:
Autumn J McRee Bert H O'Neil

Oncology (Williston Park) 2015 Jul;29(7):523-4, C3

View Article and Find Full Text PDF
July 2015

Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss.

Authors:
Adam B Sendor Kathryn E Hacker Shufen Chen Armando L Corona Oishee Sen Derek Y Chiang Anna Snavely Arlin B Rogers Stephanie A Montgomery W Kimryn Rathmell Autumn J McRee

Gastrointest Cancer 2015 Feb;5:61-71

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

View Article and Find Full Text PDF
February 2015

Everolimus and pasireotide for advanced and metastatic hepatocellular carcinoma.

Authors:
Hanna K Sanoff Richard Kim Anastasia Ivanova Angela Alistar Autumn J McRee Bert H O'Neil

Invest New Drugs 2015 Apr 23;33(2):505-9. Epub 2015 Jan 23.

Division of Hematology and Oncology, University of North Carolina at Chapel Hill, 170 Manning Drive, CB 7305, Chapel Hill, NC, 27599, USA,

View Article and Find Full Text PDF
April 2015

A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors.

Authors:
Autumn J McRee Janine M Davies Hanna G Sanoff Richard M Goldberg Stephen Bernard E Claire Dees Kimberly Keller Anastasia Ivanova Bert H O'Neil

Cancer Chemother Pharmacol 2014 Jul 13;74(1):117-23. Epub 2014 May 13.

Department of Medicine, Division of Hematology/Oncology, School of Medicine, The University of North Carolina at Chapel Hill, Physicians Office Building, 170 Manning Drive, Campus Box #7305, Chapel Hill, NC, 27599, USA,

View Article and Find Full Text PDF
July 2014